Literature DB >> 3290109

Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection.

M B Ranawaka1, Y D Munesinghe, D M de Silva, R Carter, K N Mendis.   

Abstract

The infectivity to mosquitoes of 31 acute Plasmodium vivax patients was measured by permitting mosquitoes to feed directly on the patients. The infectivity of these patients correlated closely with titers of antibodies in their serum as measured by indirect immunofluorescence against air-dried female gametes of P. vivax. Infectivity by direct feeding was also closely parallel to the transmission-blocking activity of the sera of patients as measured by the suppression of infectivity of parasitized blood by autologous serum relative to normal (nonmalarial) human serum when fed to mosquitoes through a membrane. These results are consistent with serum antibodies in human P. vivax infections as major factors determining the infectivity of an infected individual to mosquitoes. It was further noted that individuals having a second attack of P. vivax within less than 4 months were considerably less infectious to mosquitoes than first-attack patients were. This "boosting" of transmission-blocking immunity was much less if longer intervals intervened between attacks. We discuss the immunological implications and possible epidemiological significance of this short-term boosting of transmission-blocking immunity by successive P. vivax infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290109      PMCID: PMC259483          DOI: 10.1128/iai.56.7.1820-1824.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  7 in total

1.  Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection.

Authors:  P Druilhe; O Pradier; J P Marc; F Miltgen; D Mazier; G Parent
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

2.  Role of T cells in preventing transmission of rodent malaria.

Authors:  P G Harte; N C Rogers; G A Targett
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

3.  Plasmodium gallinaceum: Transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection.

Authors:  R Carter; R W Gwadz; I Green
Journal:  Exp Parasitol       Date:  1979-04       Impact factor: 2.011

4.  Plasmodium knowlesi: persistence of transmission blocking immunity in monkeys immunized with gamete antigens.

Authors:  R W Gwadz; L C Koontz
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  A metropolitan hospital in a non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka.

Authors:  J Fonseka; K N Mendis
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

6.  Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria.

Authors:  E H Nardin; R S Nussenzweig; I A McGregor; J H Bryan
Journal:  Science       Date:  1979-11-02       Impact factor: 47.728

7.  Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.

Authors:  K N Mendis; Y D Munesinghe; Y N de Silva; I Keragalla; R Carter
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

  7 in total
  11 in total

1.  A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area.

Authors:  A P De Zoysa; C Mendis; A C Gamage-Mendis; S Weerasinghe; P R Herath; K N Mendis
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

2.  Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei.

Authors:  N Tirawanchai; L A Winger; J Nicholas; R E Sinden
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

Review 3.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 4.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Will Roeffen; Adrian J F Luty; Sake J de Vlas; Issa Nebie; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Karina Teleen; Alfred B Tiono; Sodiomon Bienvenu Sirima; Jan-Peter Verhave; Teun Bousema; Robert Sauerwein
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

6.  Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Leonardo Rocha; Diego Alvarez; John C Beier; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 7.  Utilizing direct skin feeding assays for development of vaccines that interrupt malaria transmission: A systematic review of methods and case study.

Authors:  Elizabeth B Brickley; Mamadou Coulibaly; Erin E Gabriel; Sara A Healy; Jen C C Hume; Issaka Sagara; Sekou F Traore; Ogobara Doumbo; Patrick E Duffy
Journal:  Vaccine       Date:  2016-10-24       Impact factor: 3.641

8.  Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.

Authors:  Diana Haddad; Jorge Maciel; Nirbhay Kumar
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.

Authors:  Sara E White; Steven A Harvey; Graciela Meza; Alejandro Llanos; Mitchel Guzman; Dionicia Gamboa; Joseph M Vinetz
Journal:  Malar J       Date:  2018-04-27       Impact factor: 2.979

10.  Is global health really global?

Authors:  Peter Byass
Journal:  Glob Health Action       Date:  2013-03-27       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.